WidePoint CFO Robert George to Resign, Will Assist Through Transition

WIDEPOINT CORP (WYY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1

WidePoint (WYY) reported Q2 2026 revenue up 1.9% year over year and discussed CWMS 3.0 and ATV contract timelines. The CWMS 3.0 award is under GAO protest, with a decision expected by Oct 7, 2026. Costs are rising from SEC filer transition and other items, while CWMS 3.0 scale is expected in 2027-2028.

WidePoint Corp (NYSE American: WYY) said it received about $58 million in new and renewal contract awards in the first half of 2026. It cited a $1.0 million SaaS-related purchase order, a $1.5 million managed services expansion, and a Virginia ABC renewal through June 30, 2027. It also noted being the single awardee on DHS CWMS 3.0 (up to $3.1 billion ceiling) and a prime on NASA SEWP VI.

WidePoint (NYSE American: WYY) said it was named a prime contract awardee on NASA’s SEWP VI, a multiple-award GWAC with a $60 billion procurement ceiling. The contract has a five-year base plus five one-year options, with task orders potentially extending up to 15 years. WidePoint expects to use the vehicle to sell integrated IT, cybersecurity, cloud, and managed mobile services to federal agencies.

LQR House Inc. (NASDAQ:YHC) announced Sean Dollinger stepped down as CEO, effective October 16, 2026. Leo Chen, with 10 years of executive experience, will take over. The change follows LQR's strategic shift toward securities trading via its New Zealand subsidiary, Fusion Five Continents Securities, and a tech deal with ByteDance. Dollinger will focus on a new spirits e-commerce venture.

Novartis (NVS) has discontinued a mid-stage clinical trial for a lupus treatment, marking another setback in its drug pipeline. The company's stock has risen 9% year-to-date. The decision highlights challenges in developing new therapies for autoimmune diseases.